Nasal Spray Influenza Vaccine

Added: Nov 15, 2010 2:17 pm

The Defense Logistics Agency Troop Support is soliciting proposals for the supply of Nasal Spray Influenza Virus Vaccine for the 2011/2012 flu season. Shall be a live, trivalent nasally administered vaccine intended for active immunization for the prevention of influenza. Each 0.2 ml dose shall be formulated to contain 10 median tissue culture infectious doses of live attenuated influenza virus reassortants of the strains recommended by the U.S. Public Health Service (USPHS) for the 2011/2012 season. Shall be indicated for active immunization for the prevention of disease caused by influenza A and B viruses in healthy children ages 2-17 years of age and healthy adults ages 18-49 years of age. Shall be suitable for nasal administration only. Shall be supplied in a commercially available nasal syringe unit considered acceptable to the FDA. This acquisition is authorized under 10 USC 2304 (c)(1), Only One Responsible Source. The one responsible source being solicited is Medimmune, Inc. Approximately 180,000 PG (10 dose per package) are included in this requirement. (Quantities may increase or decrease substantially pending receipt of Service Requirements.) An indefinite quantity contract is proposed. The quantities indicated are annual estimates only. The guaranteed minimum will be 75% of the annual estimate, and the contract maximum will be established at 150% of the annual estimate. The contract will have a base year with an option to extend the contract for an additional annual period. Contractor shall deliver to various locations, packaged to include temptales provided by awardee.